Skip to main content

Advertisement

Log in

Overlap of Dyspepsia in Patients with Gastroesophageal Reflux Disease: Impact of Clinical, Metabolic, and Psychosocial Characteristics

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

Gastroesophageal reflux disease (GERD) and dyspepsia are highly prevalent in the general population with significant symptom overlap, while the interaction between both remains poorly understood.

Aim

To examine whether GERD overlapping dyspepsia would have an impact on clinical and psychological features as compared with GERD alone.

Methods

We performed a cross-sectional study in a GERD cohort (n = 868) that was previously recruited from a population-based GERD survey (n = 2752). We compared the clinical and psychological factors between patients with and without dyspeptic symptoms “epigastric pain or burning.” All participants were evaluated with Reflux Disease Questionnaire score, Pittsburgh Sleep Quality Index score, Taiwanese Depression Questionnaire score, and State-Trait Anxiety Inventory score. Endoscopic findings were classified according to the Los Angeles classification.

Results

Among the GERD population, 107 subjects had overlapping “epigastric pain or burning” (GERD-D), and 761 did not have these symptoms (GERD alone). GERD-D subjects had more severe GERD symptoms and were more often associated with irritable bowel syndrome (IBS) (OR 3.54, 95% CI 1.92–6.52) as compared subjects with GERD alone. In addition, GERD-D subjects had lower quality of sleep (OR 1.11, 95% CI 1.01–1.21), higher depression (OR 1.06, 95% CI 1.02–1.10), lower blood pressure (OR 0.45, 95% CI 0.22–0.95), and higher serum total cholesterol levels (OR 2.78, 95% CI 1.36–5.67) than GERD alone.

Conclusions

GERD-D subjects are characterized with worsening clinical symptoms as well as higher psychosocial, IBS, and metabolic comorbidities, but less erosive esophagitis. Our results indicate that clinical awareness of such overlapping condition would help optimize the management of GERD in clinical practice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Abbreviations

GERD:

Gastroesophageal reflux disease

IBS:

Irritable bowel syndrome

MS:

Metabolic syndrome

LA grade:

Los Angeles classification system grade

RDQ:

Reflux Disease Diagnostic Questionnaire

PSQI:

Pittsburgh Sleep Quality Index score

TDQ:

Taiwanese Depression Questionnaire score

STAI:

State-Trait Anxiety Inventory score

WHR:

Wait-to-hip ratio

BMI:

Body mass index

EE:

Erosive oesophagitis

IR:

Insulin resistance

NSAIDs:

Nonsteroidal anti-inflammatory drugs

PPIs:

Proton pump inhibitors

H2RAs:

Histamine-2 receptor antagonists

AC:

Serum fasting blood glucose

HbA1c:

Hemoglobin A1c

TG:

Triglyceride

TC:

Total cholesterol

LDL:

Low-density lipoprotein

HDL:

High-density lipoprotein

OR:

Odds ratio

CI:

Confidence interval

SBP:

Systolic blood pressure

DBP:

Diastolic blood pressure

References

  1. Tack J, Becher A, Mulligan C, et al. Systematic review: the burden of disruptive gastro-oesophageal reflux disease on health-related quality of life. Aliment Pharmacol Ther. 2012;35:1257–1266.

    Article  CAS  PubMed  Google Scholar 

  2. Sandler RS, Everhart JE, Donowitz M, et al. The burden of selected digestive diseases in the United States. Gastroenterology. 2002;122:1500–1511.

    Article  PubMed  Google Scholar 

  3. Lee YC, Yen AM, Tai JJ, et al. The effect of metabolic risk factors on the natural course of gastro-oesophageal reflux disease. Gut. 2009;58:174–181.

    Article  PubMed  Google Scholar 

  4. Goh KL. Gastroesophageal reflux disease in Asia: a historical perspective and present challenges. J Gastroenterol Hepatol. 2011;26:2–10.

    Article  Google Scholar 

  5. Lee YC, Wang HP, Chiu HM, et al. Comparative analysis between psychological and endoscopic profiles in patients with gastroesophageal reflux disease: a prospective study based on screening endoscopy. J Gastroenterol Hepatol. 2006;21:798–804.

    Article  PubMed  Google Scholar 

  6. Lei WY, Yu HC, Wen SH, et al. Predictive factors of silent reflux in subjects with erosive esophagitis. Dig Liver Dis. 2015;47:24–29.

    Article  PubMed  Google Scholar 

  7. Hsu CS, Liu TT, Wen SH, et al. Clinical, metabolic, and psychological characteristics in patients with gastroesophageal reflux disease overlap with irritable bowel syndrome. Eur J Gastroenterol Hepatol. 2015;27:516–522.

    Article  CAS  PubMed  Google Scholar 

  8. Ford AC, Forman D, Bailey AG, et al. Irritable bowel syndrome: a 10-yr natural history of symptoms and factors that influence consultation behavior. Am J Gastroenterol. 2008;103:1229–1239. (quiz 40).

    Article  PubMed  Google Scholar 

  9. Kennedy TM, Jones RH, Hungin AP, et al. Irritable bowel syndrome, gastro-oesophageal reflux, and bronchial hyper-responsiveness in the general population. Gut. 1998;43:770–774.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Lovell RM, Ford AC. Prevalence of gastro-esophageal reflux-type symptoms in individuals with irritable bowel syndrome in the community: a meta-analysis. Am J Gastroenterol. 2012;107:1793–1801. (quiz 802).

    Article  PubMed  Google Scholar 

  11. Miwa H, Ghoshal UC, Gonlachanvit S, et al. Asian consensus report on functional dyspepsia. J Neurogastroenterol Motil. 2012;18:150–168.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Park H. Functional gastrointestinal disorders and overlap syndrome in Korea. J Gastroenterol Hepatol. 2011;26:12–14.

    Article  PubMed  Google Scholar 

  13. Ghoshal UC, Singh R, Chang FY, et al. Epidemiology of uninvestigated and functional dyspepsia in Asia: facts and fiction. J Neurogastroenterol Motil. 2011;17:235–244.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Manabe N, Haruma K, Hata J, et al. Clinical characteristics of Japanese dyspeptic patients: is the Rome III classification applicable? Scand J Gastroenterol. 2010;45:567–572.

    Article  PubMed  Google Scholar 

  15. Kitapcioglu G, Mandiracioglu A, Caymaz Bor C, et al. Overlap of symptoms of dyspepsia and gastroesophageal reflux in the community. Turk J Gastroenterol. 2007;18:14–19.

    PubMed  Google Scholar 

  16. Lee SY, Lee KJ, Kim SJ, et al. Prevalence and risk factors for overlaps between gastroesophageal reflux disease, dyspepsia, and irritable bowel syndrome: a population-based study. Digestion. 2009;79:196–201.

    Article  PubMed  Google Scholar 

  17. Yarandi SS, Christie J. Functional dyspepsia in review: pathophysiology and challenges in the diagnosis and management due to coexisting gastroesophageal reflux disease and irritable bowel syndrome. Gastroenterol Res Pract. 2013;2013:351086.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Cao Y, Yan X, Ma XQ, et al. Validation of a survey methodology for gastroesophageal reflux disease in China. BMC Gastroenterol. 2008;8:37.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Hsu CS, Liu WL, Chao YC, et al. Adipocytokines and liver fibrosis stages in patients with chronic hepatitis B virus infection. Hepatol Int. 2015;9:231–242.

    Article  PubMed  Google Scholar 

  20. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006;130:1377–1390.

    Article  PubMed  Google Scholar 

  21. Buysse DJ, Reynolds CF III, Monk TH, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193–213.

    Article  CAS  PubMed  Google Scholar 

  22. Lee Y, Yang MJ, Lai TJ, et al. Development of the Taiwanese Depression Questionnaire. Chang Gung Med J. 2000;23:688–694.

    CAS  PubMed  Google Scholar 

  23. Julian LJ. Measures of anxiety: State-Trait Anxiety Inventory (STAI), Beck Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale-Anxiety (HADS-A). Arthritis Care Res. 2011;63:S467–S472.

    Article  Google Scholar 

  24. Hsu CS, Wang CC, Wang PC, et al. Increased incidence of gastroesophageal reflux disease in patients with chronic hepatitis B virus infection. Hepatol Int. 2010;4:585–593.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Armstrong D, Bennett JR, Blum AL, et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology. 1996;111:85–92.

    Article  CAS  PubMed  Google Scholar 

  26. Shaw MJ, Talley NJ, Beebe TJ, et al. Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol. 2001;96:52–57.

    Article  CAS  PubMed  Google Scholar 

  27. Wang PC, Hsu CS, Tseng TC, et al. Male sex, hiatus hernia, and Helicobacter pylori infection associated with asymptomatic erosive esophagitis. J Gastroenterol Hepatol. 2012;27:586–591.

    Article  PubMed  Google Scholar 

  28. Grundy SM, Brewer HB Jr, Cleeman JI, et al. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109:433–438.

    Article  PubMed  Google Scholar 

  29. Hsu CS, Wang PC, Chen JH, et al. Increasing insulin resistance is associated with increased severity and prevalence of gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2011;34:994–1004.

    Article  CAS  PubMed  Google Scholar 

  30. Gwee KA, Bak YT, Ghoshal UC, et al. Asian consensus on irritable bowel syndrome. J Gastroenterol Hepatol. 2010;25:1189–1205.

    Article  PubMed  Google Scholar 

  31. Gwee KA, Leong YL, Graham C, et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut. 1999;44:400–406.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Mahadeva S, Goh KL. Anxiety, depression and quality of life differences between functional and organic dyspepsia. J Gastroenterol Hepatol. 2011;26:49–52.

    Article  PubMed  Google Scholar 

  33. Hartono JL, Mahadeva S, Goh KL. Anxiety and depression in various functional gastrointestinal disorders: do differences exist? J Dig Dis. 2012;13:252–257.

    Article  PubMed  Google Scholar 

  34. Ford AC, Forman D, Bailey AG, et al. The natural history of gastro-oesophageal reflux symptoms in the community and its effects on survival: a longitudinal 10-year follow-up study. Aliment Pharmacol Ther. 2013;37:323–331.

    Article  CAS  PubMed  Google Scholar 

  35. Gwee KA, Lu CL, Ghoshal UC. Epidemiology of irritable bowel syndrome in Asia: something old, something new, something borrowed. J Gastroenterol Hepatol. 2009;24:1601–1607.

    Article  PubMed  Google Scholar 

  36. Gwee KA, Wee S, Wong ML, et al. The prevalence, symptom characteristics, and impact of irritable bowel syndrome in an Asian urban community. Am J Gastroenterol. 2004;99:924–931.

    Article  PubMed  Google Scholar 

  37. Greten H, Beil FU, Schneider J, et al. Treatment of primary hypercholesterolemia: fluvastatin versus bezafibrate. Am J Med. 1994;96:55S–63S.

    Article  CAS  PubMed  Google Scholar 

  38. Gudlaugsdottir S, Verschuren W, Dees J, et al. Hypertension is frequently present in patients with reflux esophagitis or Barrett’s esophagus but not in those with non-ulcer dyspepsia. Eur J Intern Med. 2002;13:369.

    Article  PubMed  Google Scholar 

  39. Anderson LA, Cantwell MM, Watson RG, et al. The association between alcohol and reflux esophagitis, Barrett’s esophagus, and esophageal adenocarcinoma. Gastroenterology. 2009;136:799–805.

    Article  CAS  PubMed  Google Scholar 

  40. Halder SL, Locke GR III, Schleck CD, et al. Influence of alcohol consumption on IBS and dyspepsia. Neurogastroenterol Motil. 2006;18:1001–1008.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank all of whom helped to enroll and follow the study subjects. We are also grateful to the research assistants who assisted in laboratory analyses and collected clinical information. Finally, we would like to thank the anonymous reviewers and the editor for their constructive comments. All authors approved the final version of the article, including the authorship list.

Authors’ contributions

C-LC was involved in study concept and design. J-SH, T-TL, C-HY, W-YL, and C-LC were involved in acquisition of data. C-SH, S-HW, J-SH, and C-LC were involved in analysis and interpretation of data. C-SH, S-HW, J-SH, and C-LC drafted the manuscript. C-SH, S-HW, FP, and C-LC were involved in critical revision of the manuscript for important intellectual content. S-HW was involved in statistical analysis. C-SH and C-LC obtained the funding. C-SH, S-HW, and C-LC were involved in administrative, technical, or material support. C-LC was involved in study supervision.

Sources of funding and grant support

C-SH, S-HW, and C-LC had financial support from Hualien Tzu Chi Hospital and Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation for the submitted work; no financial relationships with any organizations that might have an interest in the submitted work in the previous 3 years; no other relationships or activities that could appear to have influenced the submitted work. This work was supported by grants from the Hualien Tzu Chi Hospital and Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation (TCRD-TPE-106-RT-8, TCRD-TPE-104-31, TCMMP104-02-01, TCMMP104-02-02, TCMMP104-02-03).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chien-Lin Chen.

Ethics declarations

Conflict of interest

All authors declare no other potential conflicts (financial, professional, or personal) that are relevant to the manuscript.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 46 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hsu, CS., Wen, SH., Hung, JS. et al. Overlap of Dyspepsia in Patients with Gastroesophageal Reflux Disease: Impact of Clinical, Metabolic, and Psychosocial Characteristics. Dig Dis Sci 62, 994–1001 (2017). https://doi.org/10.1007/s10620-017-4455-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-017-4455-8

Keywords

Navigation